Long Opportunity on MERCK & CONYSE:MRK appears to have found support on a trend line to the upside. Price is moving back up and I believe a long opportunity might be present here.
1MRKX trade ideas
IRON TARIHi guys!
New Iron condor, chek my last trades, and get my script for free!
Enjoy your wallet!
Tari.
MERCK & CO : BEARISH BAT PATTERN - POTENTIAL R/R 1.88% 🔔Welcome back Traders, Investors and Community!
Analysis of #MRK
If you have found this useful then help us support my page by hitting the LIKE button.
If you are not subscribed yet then please feel free to follow my page for daily updates and ideas. Thank you
It means a lot to us!
***
Strategy: Bearish BAT With potential Max R/R 1.88%
A clear chart is Always the best business card for a trader.
***
Your support and feedback will always welcome
Thank you for your time.
The information contained herein is not intended to be a source of advice or credit analysis
Regards,
Walter
it would definitely move outside 82.8/78.8- straddle / strangle Last price action is dodji and price is between two trends. It would move in one or another direction with good impulse.
Buy options - straddle / strangle construction. i would use ATR to define ranges.
MERCK buy signals on D1.MERCK (MRK), D1: Support line + Side of Bollinger bands + Hidden divergence + 2 Hammers
ABC Bullish Pullback Fishing LONG AFTER FALL IS COMPLETE from rising wedge pattern. There is NOT a clear uptrend yet. If it hits long entry price without an uptrend, Think twice before entering
MRK has fallen from a bearish rising wedge and hopefully fall is complete. Beware that rising wedge pattern has completed it's fall and that C does not change
Short interest is low
It Does look like it is trying to bottom though
Long entry only valid if price breaks entry point in a confirmed uptrend
Possible targets 2 97.6 to 102.5
Possible stop below 78.2
Not a recommendation
NV has decreased but usually increases if large players positions are threatened
Short is low
Fall from Rising and Narrowing WedgeThis pattern shows up in charts when the price moves upward with pivot highs and lows converging toward a single point known as the apex.
It differs from triangle as both trendlines slope up.
It is most often bearish at the top
NV has slacked off
But short interest is decreasing so perhaps recovering and found support
Just an observation
MRK .618 .382 TIME TO BUY AGAIN MERCK AND ALL DRUGS ARE NOW SETUP TO RALLY SHARP ONCE AGAIN i HAVE NOW MOVED TO A 85% NET LONG MRK AS OF THIS POST LOOKING FOR A VERY SHARP AND FAST RALLY OVER THE NEXT 20 TD
MRK Long, at Demand Zone High quality Fresh Demand Zone ;
Fib# 50% retracement
Entry 81.5
Stop 79.5
Target 88; reward:risk=3:1
10/28/2020 Earning.
I am not a PRO trader. I need few months to practice trading strategies.
If you like this idea, please use SIM/Demo account to try it, until my trading plans get high winning rate.
IRON TARIHi guys,
this iron condor is 3 weeks 7% strike
Short legs are 79 and 91, our probability is 82%
Enjoy your wallet!
Tari.
MERCK 87 Health BuffMERCK bullish pattern and trend.
May take some days, so possible pullback and bounce on the lower support (green line).
Could also channeling sideways, who knows. Difficult to lose with a warp speed candidate anyway.
BUY ON FRIDAY!
PT:87 at least
Stop if breaks green line.
Covid/Trump play.
$JNJ $MRK $ABT
MRK Short
resistance at 4/27 high 84.67
reversal bar on 8/14
8/14 high is above 8/3 high 83.80 (breakout fail)
Merck a strong value with strong technicals and upcoming newsI've been holding Merck since its big dip to $76 back in June. At the time I set a price target of $82:
However, I didn't sell at $82 and have continued to hold the stock due to strong fundamentals, technicals, news, and sentiment. Merck has positive earnings and sales growth, with PEG ratio of 1.7 and PSG ratio of 2.3. It has a nice dividend yield at 2.9%, a rarity for a stock with such strong growth. Analysts rate it highly, with an average score of 80.25/100 from S&P Global and an Equity Starmine Summary Score of 8.5/10. With a put/call ratio of 0.41, sentiment on Merck is stronger than on most of the other stocks I watch. It's got a good ESG score and a long history of beating analyst estimates. Plus it's poised to benefit from some hype around its antiviral drug intended to fight Covid-19 that starts clinical trials in September.
In technical terms, Merck recently broke out of a triangle, got a couple bullish moving average crosses, and today broke out above its recent trading range. If Merck oscillates down to its moving averages, I may use that as an opportunity to add to my position. I think the stock still has plenty of upside, especially when the clinical trial headlines start to hit.
